Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey
- 1 March 2013
- journal article
- Published by Elsevier BV in Annals of Allergy, Asthma & Immunology
- Vol. 110 (3), 194-197.e4
- https://doi.org/10.1016/j.anai.2012.12.014
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Specific Allergy Immunotherapy for Allergic Rhinitis: Subcutaneous and SublingualImmunology and Allergy Clinics of North America, 2011
- Allergen immunotherapy: A practice parameter third updateJournal of Allergy and Clinical Immunology, 2011
- Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adultsJournal of Allergy and Clinical Immunology, 2011
- Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescentsJournal of Allergy and Clinical Immunology, 2011
- Comparison of allergen immunotherapy practice patterns in the United States and EuropeAnnals of Allergy, Asthma & Immunology, 2009
- Perception and practice of sublingual immunotherapy among practicing allergistsAnnals of Allergy, Asthma & Immunology, 2008
- Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitisJournal of Allergy and Clinical Immunology, 2007
- Cost‐effectiveness of grass allergen tablet (GRAZAX®) for the prevention of seasonal grass pollen induced rhinoconjunctivitis – a Northern European perspectiveClinical & Experimental Allergy, 2007
- Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitisJournal of Allergy and Clinical Immunology, 2006
- Children's compliance with allergen immunotherapy according to administration routesJournal of Allergy and Clinical Immunology, 2005